// App-Quantinova.ai

9067 : Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study.

Researchers

Presenter

  • Rebecca Jane Moor

Principal Investigators

  • Kate Elizabeth Roberts

  • Robert Mason

  • Ben Gunawan

  • Sophie Feng

  • Jun Hee Hong

  • Mitchell Von Itzstein

  • Brett Gordon Maxwell Hughes

  • Zarnie Lwin

  • Vikram Kumar Jain

  • Kieron James Bigby

  • Mary W. F. Azer

  • Jasotha Sanmugarajah

  • Kenneth John O'Byrne

Medical Centers

  • Princess Alexandra Hospital and University of Queensland, Brisbane, Australia

  • Mater Hospital, Queensland, Australia

  • Redcliffe Hospital, Brisbane Queensland, Australia

  • Gold Coast University Hospital, Queensland, Australia

  • and The Prince Charles Hospital, Queensland, Australia

  • Royal Brisbane & Women's' Hospital, Queensland, Australia

  • Mater Hospital, Brisbane, Australia

  • Gold Coast University Hospital, Queensland, Australia

  • Gold Coast University Hospital & Griffith University, Queensland, Australia

  • Princess Alexandra Hospital & Queensland University of Technology, Brisbane, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved